CYTOKINETICS, INCORPORATED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 65.34 USD | +0.83% |
|
-3.27% | -21.74% |
| 04-26 | Cytokinetics Appoints Sung Lee as CFO | MT |
| 04-26 | Cytokinetics, Incorporated Appoints Sung H. Lee as Executive Vice President, Effective as of May 8, 2024 | CI |
Chart calendar Cytokinetics, Incorporated
4cae6e9b6f806684a303df.Nc_LdcqEcmVh5m0qXILPNLiIsYvX0IGU91EkkA2BkjQ.AeKeR4_CFSElnyh4JfWpUpXk2ei14qz7xhtL_kH78HBwtrEb8_caCzjSCg~9b5fff402f27b19d8995dba32cf0c0af
Upcoming events on Cytokinetics, Incorporated
Past events on Cytokinetics, Incorporated
| 08/04/2024 19:15 | Needham Healthcare Conference |
| 07/04/2024 19:00 | American College of Cardiology Scientific Meeting - Sara Saberi |
| 07/04/2024 18:00 | American College of Cardiology Scientific Meeting - Nosheen Reza |
| 07/04/2024 14:15 | American College of Cardiology Scientific Meeting - Tristan B. Post |
| 06/04/2024 15:45 | American College of Cardiology Scientific Meeting - Morris M. Kim |
| 06/04/2024 15:45 | American College of Cardiology Scientific Meeting - Morris M. Kim |
| 13/03/2024 13:00 | Barclays Global Healthcare Conference |
| 11/03/2024 | Jefferies Biotech on the Bay Summit |
| 11/03/2024 17:20 | Leerink Partners Global Biopharma Conference |
| 27/02/2024 21:30 | Q4 2023 Earnings Call |
| 27/02/2024 21:00 | Q4 2023 Earnings Release |
| 13/02/2024 15:40 | Oppenheimer Healthcare Life Sciences Conference |
| 25/01/2024 14:55 | CMR Conference |
| 08/01/2024 15:30 | JPMorgan Healthcare Conference |
| 27/12/2023 13:30 | SEQUOIA HCM Phase 3 Clinical Trial Results Call |
| 07/12/2023 16:45 | ALS And MND International Conference - Poster No: CMS-53 |
| 07/12/2023 16:45 | ALS And MND International Conference - Poster No: CLT-20 |
| 07/12/2023 09:30 | ALS And MND International Conference - Jeremy M. Shefner, M.D., Ph.D |
| 06/12/2023 17:45 | ALS And MND International Conference - Poster No: DSP-08 |
| 06/12/2023 14:15 | ALS And MND International Conference - Stacy Rudnicki, M.D |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 26,9 29,4 -8.54% | 55,8 58,3 -4.18% | 70,4 20,7 240.58% | 94,6 99,3 -4.74% | 7,53 24,2 -68.83% | 12,1 |
|
EBITDA Million USD | Released Forecast Spread | -97,6 -89,0 -9.62% | -92,1 -75,9 -21.38% | -184 -229 19.61% | -318 -298 -6.85% | -484 -396 -22.3% | -417 |
|
EBIT Million USD | Released Forecast Spread | -98,9 -97,9 -0.95% | -93,9 -83,0 -13.16% | -186 -226 17.38% | -324 -301 -7.58% | -496 -441 -12.62% | -448 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -122 -121 -0.86% | -127 -113 -12.24% | -215 -246 12.62% | -389 -361 -7.62% | -526 -469 -12.11% | -470 |
|
Net income Million USD | Released Forecast Spread | -122 -119 -2.23% | -127 -113 -12.57% | -215 -249 13.69% | -389 -366 -6.17% | -526 -475 -10.9% | -466 |
|
EPS USD | Released Forecast Spread | -2,11 -2,07 -2.13% | -1,97 -1,77 -11.61% | -2,80 -3,27 14.24% | -4,33 -4,05 -6.85% | -5,45 -4,88 -11.61% | -4,41 |
| Announcement Date | 03/03/20 | 25/02/21 | 24/02/22 | 01/03/23 | 27/02/24 | - |
Quarterly results
| Fiscal Period | December | 2020 S1 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 7,42 8,43 -11.98% | 55,6 5,56 900.54% | 1,15 4,72 -75.66% | 89,0 3,73 2284.05% | 2,52 3,23 -22.24% | 1,96 7,10 -72.44% | 4,61 2,50 84.75% | 0,87 6,05 -85.68% | 0,38 21,6 -98.25% | 1,67 13,3 -87.39% | 0,91 | 0,89 | 4,42 | 0,92 | 0,00 |
|
EBITDA Million USD | Released Forecast Spread | -21,0 -75,0 72.04% | -76,5 -82,0 6.69% | -9,47 -85,0 88.86% | -107 -97,0 -10.34% | -125 -112 -11.94% | -123 -110 -11.48% | -120 -77,3 -55.59% | -120 -92,0 -30.88% | -121 -33,4 -262.55% | ||||||
|
EBIT Million USD | Released Forecast Spread | -62,7 -58,6 -7.03% | -21,7 -62,0 65% | -77,9 -75,3 -3.33% | -10,9 -84,1 87.07% | -108 -97,9 -10.79% | -127 -105 -20.43% | -124 -109 -14.67% | -122 -105 -16.23% | -122 -69,7 -75.47% | -127 -89,9 -41.77% | -116 | -113 | -107 | -112 | -122 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -80,2 -75,4 -6.35% | -30,6 -67,3 54.56% | -89,4 -79,2 -13% | -19,8 -87,9 77.45% | -142 -103 -37.55% | -137 -113 -21.26% | -131 -117 -12.57% | -129 -112 -15.21% | -129 -80,2 -61.29% | -137 -95,9 -42.7% | -122 | -120 | -114 | -119 | -122 |
|
Net income Million USD | Released Forecast Spread | -80,2 -75,4 -6.35% | -30,6 -68,3 55.24% | -89,4 -79,1 -13.01% | -19,8 -89,5 77.87% | -142 -105 -35.87% | -137 -114 -20.26% | -131 -116 -12.79% | -129 -113 -14.34% | -129 -76,9 -68.35% | -137 -95,8 -42.89% | -119 | -118 | -114 | -120 | -122 |
|
EPS USD | Released Forecast Spread | -0,36 -0,87 58.57% | -1,05 -0,95 -10.01% | -0,23 -1,04 77.84% | -1,52 -1,17 -29.94% | -1,45 -1,21 -19.36% | -1,38 -1,21 -13.85% | -1,34 -1,16 -16% | -1,35 -0,74 -83.4% | -1,38 -0,99 -39.72% | -1,15 | -1,12 | -1,08 | -1,08 | -1,20 | |
| Announcement Date | 06/08/20 | 24/02/22 | 04/05/22 | 04/08/22 | 03/11/22 | 01/03/23 | 04/05/23 | 03/08/23 | 02/11/23 | 27/02/24 | - | - | - | - | - |
More events
Past sector events for Cytokinetics, Incorporated
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- CYTK Stock
- Calendar Cytokinetics, Incorporated
